2 Tibet Pharma Defendants May Appeal Last Count In IPO Suit
A New Jersey federal judge ruled Wednesday that two defendants in a class action accusing Tibet Pharmaceuticals Inc. of lying about its financial health before its 2011 initial public offering can...To view the full article, register now.
Already a subscriber? Click here to view full article